登士柏国际旗下创新研发的全球首款牙科专用核磁共振成像系统，近日成功完成临床试验验证，并正式获得美国食品药品监督管理局（FDA）批准上市。该突破性技术将专用于口腔领域的高精度软组织诊断，有望显著提升牙周疾病、颞下颌关节病变等口腔软组织的影像学检测水平。
登士柏国际旗下创新研发的全球首款牙科专用核磁共振成像系统，近日成功完成临床试验验证，并正式获得美国食品药品监督管理局（FDA）批准上市。该突破性技术将专用于口腔领域的高精度软组织诊断，有望显著提升牙周疾病、颞下颌关节病变等口腔软组织的影像学检测水平。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.